Ledger.Open graph →
SEC Form D · Amendment · filed April 5, 2019

Melt Pharmaceuticals, Inc

Offering
$25.8M
Sold
$11.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Andrew Boll · San Diego, CADirectorLarry Dillaha · San Diego, CADirectorJohn Berdahl · San Diego, CADirectorMark Baum · San Diego, CADirectorGregory Madison · San Diego, CAExec · DirectorRandy Domolky · Vienna, VADirectorMcgowan Jonathan · Portland, ORDirectorArtem Milinchuk · San Francisco, CAExec · DirectorDavid A. Chan · San Francisco, CADirectorMarvin E. Key · Dallas, TXDirectorTerrance Mcguire · Boston, MADirectorTillman Gerngross · Boston, MADirectorTobias W. Seth · Boston, MADirectorClinton W. Liebenberg · Boston, MAExec · DirectorStanley B. Miranda · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗